Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11702088Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
FY2026 award categories
- Microbiology & Immunology
NIH Funding · FY2026
Linked Award Amount
$1.2M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#16,653
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $1.2M in linked award amounts across 2 award records · Award-linked rank #16653.
FY2026 award records by amount
NIH award records listing Mobin Karimi as a PI. Multi-PI records show the full award amount for context.
- 1R01CA308325-01A1R01Harnessing β-Catenin and NK2GD to enable HLA-Independent CD8+ T Cell immunotherapy Against AML$724.2Kaward amount
- $461.1Kaward amount
Award organization
Organizations that administered FY2026 awards listing Mobin Karimi as a PI.
FY2026 award administered by SUNY Upstate Medical University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardSUNY Upstate Medical University
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding